US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist
  • 0.4100
  • +0.0650+18.84%
Close Dec 26 16:00 ET
  • 0.4297
  • +0.0197+4.80%
Pre 08:19 ET
8.63MMarket Cap-13.67P/E (TTM)

T2 Biosystems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
53.32%-6.25M
25.40%-9.24M
9.71%-11.68M
4.92%-48.14M
8.84%-9.42M
15.78%-13.39M
-24.42%-12.39M
10.39%-12.94M
-30.24%-50.63M
-4.95%-10.33M
Net income from continuing operations
34.41%-10.12M
-41.22%-8.96M
24.66%-13.53M
19.23%-50.08M
-2.39%-10.34M
11.22%-15.43M
64.81%-6.35M
-8.91%-17.97M
-25.92%-62M
16.84%-10.1M
Operating gains losses
-153.35%-398K
87.38%-1.04M
-96.15%80K
-754.04%-5.42M
96.48%-31K
2,160.61%746K
---8.21M
--2.08M
180.96%829K
---881K
Depreciation and amortization
-77.48%59K
-76.78%62K
-75.00%64K
-17.96%859K
-70.98%74K
0.77%262K
8.54%267K
-10.49%256K
-58.75%1.05M
-54.14%255K
Other non cash items
-17.34%515K
-53.74%396K
-53.89%705K
9.74%3.68M
-19.24%676K
-28.31%623K
5.16%856K
82.68%1.53M
-14.67%3.36M
-17.70%837K
Change In working capital
216.27%3.47M
-32.61%93K
11.49%-593K
-703.58%-4.04M
67.85%-523K
-181.26%-2.99M
-96.38%138K
58.67%-670K
76.83%-503K
-118.68%-1.63M
-Change in receivables
-450.48%-736K
1,219.23%291K
-120.00%-168K
-74.99%743K
51.97%-281K
-81.63%210K
-101.59%-26K
8.67%840K
8,588.57%2.97M
35.86%-585K
-Change in inventory
914.55%1.34M
-186.78%-499K
115.70%149K
21.60%-744K
-52.99%-205K
-115.46%-165K
265.23%575K
38.14%-949K
51.08%-949K
-436.00%-134K
-Change in prepaid assets
139.98%421K
87.61%818K
13.04%156K
-216.77%-550K
-161.74%-71K
-196.62%-1.05M
-80.06%436K
109.35%138K
200.86%471K
-48.89%115K
-Change in payables and accrued expense
277.25%2.88M
75.32%-153K
16.14%-317K
-70.27%-2.22M
169.22%398K
36.62%-1.62M
-180.10%-620K
-135.83%-378K
-185.29%-1.31M
-248.20%-575K
-Change in other current liabilities
-19.77%-412K
-19.52%-398K
-19.69%-383K
1.24%-1.35M
29.14%-355K
-15.05%-344K
-14.43%-333K
-15.11%-320K
-18.94%-1.37M
-65.35%-501K
-Change in other working capital
-46.15%-19K
-67.92%34K
-2,900.00%-30K
125.78%83K
-116.98%-9K
77.97%-13K
168.39%106K
99.38%-1K
-198.15%-322K
145.30%53K
Cash from discontinued investing activities
Operating cash flow
53.32%-6.25M
25.40%-9.24M
9.71%-11.68M
4.92%-48.14M
8.84%-9.42M
15.78%-13.39M
-24.42%-12.39M
10.39%-12.94M
-30.24%-50.63M
-4.95%-10.33M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-101.99%-192K
27.78%-26K
89.68%-13K
-100.34%-33K
-313.79%-120K
-61.04%9.66M
-100.37%-36K
Net PPE purchase and sale
--0
--0
--0
43.36%-192K
27.78%-26K
89.68%-13K
77.70%-33K
-313.79%-120K
26.30%-339K
81.91%-36K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
-60.41%10M
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-101.99%-192K
27.78%-26K
89.68%-13K
-100.34%-33K
-313.79%-120K
-61.04%9.66M
-100.37%-36K
Financing cash flow
Cash flow from continuing financing activities
-81.11%4.09M
-60.41%7.28M
-81.41%2.2M
81.35%52.69M
8.56%812K
-6.65%21.64M
368.94%18.39M
885.69%11.85M
41.49%29.05M
212.97%748K
Net common stock issuance
-81.16%4.09M
-60.46%7.27M
-81.41%2.2M
80.82%52.73M
-24.43%795K
-5.16%21.7M
384.58%18.39M
727.37%11.85M
46.04%29.16M
--1.05M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
---30K
---330K
Proceeds from stock option exercised by employees
--0
----
----
-88.48%19K
-34.62%17K
--0
----
----
-70.90%165K
-89.12%26K
Net other financing activities
--0
--0
---1K
74.49%-62K
--0
----
----
----
---243K
--0
Cash from discontinued financing activities
Financing cash flow
-81.11%4.09M
-60.41%7.28M
-81.41%2.2M
81.35%52.69M
8.56%812K
-6.65%21.64M
368.94%18.39M
885.69%11.85M
41.49%29.05M
212.97%748K
Net cash flow
Beginning cash position
-71.16%4.8M
-36.64%6.76M
36.70%16.24M
-50.08%11.88M
15.69%24.87M
15.98%16.64M
1.33%10.67M
-50.08%11.88M
37.20%23.8M
-8.90%21.5M
Current changes in cash
-126.27%-2.16M
-132.88%-1.96M
-682.26%-9.48M
136.59%4.36M
10.26%-8.63M
15.11%8.24M
56.41%5.97M
90.87%-1.21M
-284.69%-11.92M
-4,957.07%-9.62M
End cash Position
-89.41%2.63M
-71.16%4.8M
-36.64%6.76M
36.70%16.24M
36.70%16.24M
15.69%24.87M
15.98%16.64M
1.33%10.67M
-50.08%11.88M
-50.08%11.88M
Free cash flow
53.36%-6.25M
25.60%-9.24M
10.54%-11.68M
5.18%-48.33M
8.90%-9.44M
16.36%-13.41M
-22.92%-12.42M
9.74%-13.06M
-29.58%-50.97M
-3.23%-10.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 53.32%-6.25M25.40%-9.24M9.71%-11.68M4.92%-48.14M8.84%-9.42M15.78%-13.39M-24.42%-12.39M10.39%-12.94M-30.24%-50.63M-4.95%-10.33M
Net income from continuing operations 34.41%-10.12M-41.22%-8.96M24.66%-13.53M19.23%-50.08M-2.39%-10.34M11.22%-15.43M64.81%-6.35M-8.91%-17.97M-25.92%-62M16.84%-10.1M
Operating gains losses -153.35%-398K87.38%-1.04M-96.15%80K-754.04%-5.42M96.48%-31K2,160.61%746K---8.21M--2.08M180.96%829K---881K
Depreciation and amortization -77.48%59K-76.78%62K-75.00%64K-17.96%859K-70.98%74K0.77%262K8.54%267K-10.49%256K-58.75%1.05M-54.14%255K
Other non cash items -17.34%515K-53.74%396K-53.89%705K9.74%3.68M-19.24%676K-28.31%623K5.16%856K82.68%1.53M-14.67%3.36M-17.70%837K
Change In working capital 216.27%3.47M-32.61%93K11.49%-593K-703.58%-4.04M67.85%-523K-181.26%-2.99M-96.38%138K58.67%-670K76.83%-503K-118.68%-1.63M
-Change in receivables -450.48%-736K1,219.23%291K-120.00%-168K-74.99%743K51.97%-281K-81.63%210K-101.59%-26K8.67%840K8,588.57%2.97M35.86%-585K
-Change in inventory 914.55%1.34M-186.78%-499K115.70%149K21.60%-744K-52.99%-205K-115.46%-165K265.23%575K38.14%-949K51.08%-949K-436.00%-134K
-Change in prepaid assets 139.98%421K87.61%818K13.04%156K-216.77%-550K-161.74%-71K-196.62%-1.05M-80.06%436K109.35%138K200.86%471K-48.89%115K
-Change in payables and accrued expense 277.25%2.88M75.32%-153K16.14%-317K-70.27%-2.22M169.22%398K36.62%-1.62M-180.10%-620K-135.83%-378K-185.29%-1.31M-248.20%-575K
-Change in other current liabilities -19.77%-412K-19.52%-398K-19.69%-383K1.24%-1.35M29.14%-355K-15.05%-344K-14.43%-333K-15.11%-320K-18.94%-1.37M-65.35%-501K
-Change in other working capital -46.15%-19K-67.92%34K-2,900.00%-30K125.78%83K-116.98%-9K77.97%-13K168.39%106K99.38%-1K-198.15%-322K145.30%53K
Cash from discontinued investing activities
Operating cash flow 53.32%-6.25M25.40%-9.24M9.71%-11.68M4.92%-48.14M8.84%-9.42M15.78%-13.39M-24.42%-12.39M10.39%-12.94M-30.24%-50.63M-4.95%-10.33M
Investing cash flow
Cash flow from continuing investing activities 000-101.99%-192K27.78%-26K89.68%-13K-100.34%-33K-313.79%-120K-61.04%9.66M-100.37%-36K
Net PPE purchase and sale --0--0--043.36%-192K27.78%-26K89.68%-13K77.70%-33K-313.79%-120K26.30%-339K81.91%-36K
Net investment purchase and sale --------------0-----------------60.41%10M--0
Cash from discontinued investing activities
Investing cash flow --0--0--0-101.99%-192K27.78%-26K89.68%-13K-100.34%-33K-313.79%-120K-61.04%9.66M-100.37%-36K
Financing cash flow
Cash flow from continuing financing activities -81.11%4.09M-60.41%7.28M-81.41%2.2M81.35%52.69M8.56%812K-6.65%21.64M368.94%18.39M885.69%11.85M41.49%29.05M212.97%748K
Net common stock issuance -81.16%4.09M-60.46%7.27M-81.41%2.2M80.82%52.73M-24.43%795K-5.16%21.7M384.58%18.39M727.37%11.85M46.04%29.16M--1.05M
Net preferred stock issuance --------------0-------------------30K---330K
Proceeds from stock option exercised by employees --0---------88.48%19K-34.62%17K--0---------70.90%165K-89.12%26K
Net other financing activities --0--0---1K74.49%-62K--0---------------243K--0
Cash from discontinued financing activities
Financing cash flow -81.11%4.09M-60.41%7.28M-81.41%2.2M81.35%52.69M8.56%812K-6.65%21.64M368.94%18.39M885.69%11.85M41.49%29.05M212.97%748K
Net cash flow
Beginning cash position -71.16%4.8M-36.64%6.76M36.70%16.24M-50.08%11.88M15.69%24.87M15.98%16.64M1.33%10.67M-50.08%11.88M37.20%23.8M-8.90%21.5M
Current changes in cash -126.27%-2.16M-132.88%-1.96M-682.26%-9.48M136.59%4.36M10.26%-8.63M15.11%8.24M56.41%5.97M90.87%-1.21M-284.69%-11.92M-4,957.07%-9.62M
End cash Position -89.41%2.63M-71.16%4.8M-36.64%6.76M36.70%16.24M36.70%16.24M15.69%24.87M15.98%16.64M1.33%10.67M-50.08%11.88M-50.08%11.88M
Free cash flow 53.36%-6.25M25.60%-9.24M10.54%-11.68M5.18%-48.33M8.90%-9.44M16.36%-13.41M-22.92%-12.42M9.74%-13.06M-29.58%-50.97M-3.23%-10.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Adobe
ADBE
+0.50%
Lennar Corp
LEN
+0.46%
Petroleo Brasileiro SA Petrobras
PBR
+0.46%
Apple
AAPL
+0.32%
D.R. Horton
DHI
+0.30%

Unlock the Full List

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.30%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.42%